Purchase Order V663P80406

This contract award, with ID HHSN272201400892P, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Aalto Bio Reagents LIMITED, a for-profit limited liability company. The $3,935.00 firm fixed-price contract is for the purchase of an unspecified antibody product, with a completion date of September 15, 2014. The contract did not utilize any set-aside designations. Without additional information on the original...

The U.S. Department of Health and Human Services (HHS), through the National Institute of Allergy and Infectious Diseases (NIAID), awarded a $5,286.50 firm-fixed-price purchase order to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) for custom antibody generation services. The award, with a completion date of December 18, 2013, is not associated with a set-aside designation. Precision Antibody is a for-profit manufacturer of goods specializing in custom antibody...

This federal contract award, valued at $443,276.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Advanced Bioscience Laboratories, Inc. (ABL), a leading contract research and manufacturing organization. The contract is for the production of a Master Cell Bank and formulation development in support of an Amyotrophic Lateral Sclerosis (ALS) gene therapy program. ABL, a for-profit manufacturer, will...

The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $132,862.50 firm fixed price delivery order contract to A&G Pharmaceutical, Inc., doing business as Precision Antibody, to support the agency's research efforts. Under the contract, TO6 - GENERATING MONOCLONAL CELL LINES, MONOCLONAL ANTIBODIES, AND LABELED MONOCLONAL ANTIBODIES AGAINST HUMAN AND MOUSE COLQ, Precision Antibody will provide monoclonal cell...

Immuno Mycologies Inc. was awarded a $299,593 firm fixed price definitive contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to develop an easy-to-use diagnostic test capable of early, rapid detection of Talaromyces antigen in human serum, plasma, and/or urine. This contract was awarded under the Small Business Innovation Research Program Phase I solicitation issued by NIH and the Centers for Disease Control and Prevention seeking proposals to...

This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Research And Diagnostic Systems, Inc. (R&D Systems) for the delivery of antibodies. The $3,145.50 firm fixed-price purchase order did not have a set-aside designation. R&D Systems is a subsidiary of Bio-Techne Corporation, a major provider of life sciences research tools and reagents, which has been awarded numerous...

The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a $3,206.25 firm fixed-price purchase order contract to Takara Bio USA, Inc., a prominent provider of specialized biomedical products and services to the federal government. The contract is for the supply of the SMARTER Ultra Low RNA Kit for the Fluidigm C1 System (CAT#634832), a critical tool used in advanced genomics research. As a subsidiary of the Japanese biotechnology company Takara Bio Inc., Takara Bio USA...

The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $105,669.50 firm fixed price delivery order to A&G Pharmaceutical, Inc., doing business as Precision Antibody, for Task Order 7 under the DOK7 contract vehicle. Precision Antibody will provide custom antibody development services in support of biomedical research at the Center's location in Potomac, Maryland by the stated completion date of March 17, 2025....

This federal contract award to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey, is for the delivery of custom rabbit monoclonal antibodies to support the development of diagnostic tests for taeniasis and cysticercosis. The award, valued at $49,981.00, was made by the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia and has a period of performance from September 30, 2024 to April 22, 2025. The original solicitation, a Request for Quotations (RFQ), was...

This is a $299,999.00 Small Business Innovation Research (SBIR) Program Phase I contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to Abzyme Therapeutics LLC, a minority-owned and Asian-Pacific American-owned limited liability company. The contract is for research and development services related to the "MONOCLONAL ANTIBODIES TO RNA-MODIFICATIONS (MOONSHOT)" project, which involves developing modular...